1. Market Research
  2. > Healthcare Market Trends
  3. > Bayer HealthCare AG - Product Pipeline Analysis, 2015 Update

Summary

Bayer HealthCare AG (Bayer Healthcare), a division of the Bayer Group, is a healthcare company. It undertakes the design, research, development, manufacture and sale of medical products for the healthcare industry. The company develops innovative products such as animal healthcare products, consumer care products, blood glucose monitoring systems, diagnostic imaging products, cancer products and primary care products. Its general medicine primarily includes cardiovascular health and women’s healthcare productsand specialty medicine including medicines that are principally prescribed by specialist physicians. Bayer Healthcare’s products are marketed across the world through regional and national distribution companies. Bayer Healthcare is headquartered in Leverkusen, Germany.Bayer Healthcare focuses on enhancing its market share through strategic alliances and acquisitions. In line with this strategy, the company recently collaborated with Broad Institute of MIT and Harvard to develop therapies for cardiovascular disease.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Bayer HealthCare AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Bayer HealthCare AG - Product Pipeline Analysis, 2015 Update
Table of Contents
Table of Contents 2
List of Tables 4
List of Figuress 5
Bayer HealthCare AG Company Snapshot 6
Bayer HealthCare AG Company Overview 6
Key Information 6
Bayer HealthCare AG Pipeline Products and Clinical Trials Overview 7
Bayer HealthCare AG - Pipeline Analysis Overview 9
Business Description 9
Key Facts 9
Bayer HealthCare AG - Major Products and Services 10
Bayer HealthCare AG Pipeline Products by Development Stage 12
Bayer HealthCare AG Pipeline Products Overview 13
Companion Diagnostic DNA Test 13
Companion Diagnostic DNA Test Product Overview 13
iSense Diagnostic Test - Sepsis 14
iSense Diagnostic Test - Sepsis Product Overview 14
LNG-IUS16 15
LNG-IUS16 Product Overview 15
Next Generation Blood Glucose Monitoring System 16
Next Generation Blood Glucose Monitoring System Product Overview 16
Thrombectomy System 17
Thrombectomy System Product Overview 17
Bayer HealthCare AG - Key Competitors 18
Bayer HealthCare AG - Key Employees 19
Bayer HealthCare AG - Key Employee Biographies 21
Bayer HealthCare AG - Locations And Subsidiaries 22
Head Office 22
Other Locations and Subsidiaries 22
Recent Developments 25
Bayer HealthCare AG, Recent Developments 25
Apr 22, 2015: FDA Accepts Filing of BETACONNECT for Relapsing-Remitting Multiple Sclerosis Patients Taking BETASERON (interferon beta-1b) 25
Apr 01, 2015: Mirena Litigation News: 15 Cases to be selected for Eligibility for Second Trial, Says Lawsuitsettlementnews.com 25
Feb 19, 2015: Olivier Brandicourt to leave Bayer HealthCare 25
Feb 09, 2015: Bayer HealthCare's Bayer Aspirin Launches The ProHeart Path Tool to Assess CV Event Risk 26
Jan 08, 2015: Blood Glucose Meters from Bayer Rank Highest in Overall Satisfaction in J.D. Power Study 27
Jan 05, 2015: FDA approves Bayer's Gadavist injection as the first magnetic resonance contrast agent for pediatric patients less than 2 years of age 27
Dec 01, 2014: Bayer launches new version of Radimetrics at RSNA expanding radiation dose management and contrast analytics capabilities 28
Nov 03, 2014: Bayer HealthCare and KARL STORZ Enter Collaboration Agreement to Provide Gynecologists Hysteroscopy Solutions Supporting the Procedure for Essure Permanent Birth Control 29
Jun 04, 2014: Bayer's Erica Mann Chairs World Self-Medication Industr 30
May 23, 2014: Bayer Introduces First Bluetooth-enabled Injection Management System for Multiple Sclerosis Patients 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Bayer HealthCare AG, Key Facts 6
Bayer HealthCare AG Pipeline Products and Clinical Trials Overview 7
Bayer HealthCare AG Pipeline Products by Equipment Type 7
Bayer HealthCare AG Pipeline Products by Indication 8
Bayer HealthCare AG, Key Facts 9
Bayer HealthCare AG, Major Products and Services 10
Bayer HealthCare AG Number of Pipeline Products by Development Stage 12
Bayer HealthCare AG Pipeline Products Summary by Development Stage 12
Companion Diagnostic DNA Test - Product Status 13
Companion Diagnostic DNA Test - Product Description 13
iSense Diagnostic Test - Sepsis - Product Status 14
iSense Diagnostic Test - Sepsis - Product Description 14
LNG-IUS16 - Product Status 15
LNG-IUS16 - Product Description 15
Next Generation Blood Glucose Monitoring System - Product Status 16
Next Generation Blood Glucose Monitoring System - Product Description 16
Thrombectomy System - Product Status 17
Thrombectomy System - Product Description 17
Bayer HealthCare AG, Key Employees 19
Bayer HealthCare AG, Key Employee Biographies 21
Bayer HealthCare AG, Other Locations 22
Bayer HealthCare AG, Subsidiaries 24

List of Figuress
Bayer HealthCare AG Pipeline Products by Equipment Type 8
Bayer HealthCare AG Pipeline Products by Development Stage 12

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Tetanus - Pipeline Review, H2 2016

Tetanus - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Tetanus - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tetanus - Pipeline Review, H2 2016’, provides an overview of the Tetanus pipeline landscape. The report provides comprehensive ...

Hepatitis A - Pipeline Review, H2 2016

Hepatitis A - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatitis A - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A – Pipeline Review, H2 2016, provides an overview of the ...

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2016

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.